To further investigate the potential of T. gondii ME49Δompdc/gra4 induced CD64+MAR‐1+CD11b+ DCs in anti‐tumor activity, we established an in vivo adoptive transfer model. The gene discussed is ITGAM; the disease is neoplasm.